Verified Nov 2026
Other
·

Mumbai, Maharashtra
·
Since 1935
Cipla Limited is a multinational pharmaceutical manufacturer headquartered in Mumbai, India, founded in 1935. The company employs 10,000–50,000 people and generates $1–5 billion in estimated annual revenue. It produces over 1,500 medicines across respiratory, cardiovascular, anti-retroviral, and oncology therapeutic areas, serving automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors across 74–86 countries. Recent expansion includes a planned $100 million investment in its US subsidiary for manufacturing and product launches.
Cipla at a glance
Revenue
$1-5B
Est. band
Employees
10,000-50,000
Founded
1935
Headquarters
Mumbai, Maharashtra
Certifications
ISO 14001 · ISO 45001 · ISO 9001
Import activity
790
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
790
Named foreign suppliers
18
Top origins
India · Oman · Spain · Netherlands

Shared foreign counterparties do not establish that these companies buy from Cipla.
What this tells a buyer
Cipla recorded 1,525 shipments in customs data and sources pharmaceutical ingredients and finished medicines from India, Portugal, Greece, China, Spain, and 7 other countries globally.
The company holds ISO 9001, ISO 14001, and ISO 45001 certifications and operates approximately 46–47 manufacturing facilities worldwide, including a site in Fall River, Massachusetts.
Cipla is drug producer in India with a workforce exceeding 26,000 employees and maintains a joint venture with Kemwell focused on biosimilars development.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
91 years in operation (founded 1935).
790 US import shipments on record.
Holds ISO 14001, ISO 45001, ISO 9001 certification(s) per public sources.
Overview
Cipla Limited is a multinational pharmaceutical manufacturer headquartered in Mumbai, India, founded in 1935. The company employs 10,000–50,000 people and generates $1–5 billion in estimated annual revenue. It produces over 1,500 medicines across respiratory, cardiovascular, anti-retroviral, and oncology therapeutic areas, serving automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors across 74–86 countries. Recent expansion includes a planned $100 million investment in its US subsidiary for manufacturing and product launches.
At a glance
Attribute | Detail |
|---|---|
Founded | 1935 |
Headquarters | Mumbai, Maharashtra |
Employees | 10,000-50,000 |
Revenue | $1-5B (estimated) |
Certifications | ISO 14001 · ISO 45001 · ISO 9001 |
What Cipla makes
The company holds ISO 9001, ISO 14001, and ISO 45001 certifications and operates approximately 46–47 manufacturing facilities worldwide, including a site in Fall River, Massachusetts.
Certifications
Cipla is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — chemicalbrowser.com
ISO 45001 — chemicalbrowser.com
ISO 9001 — chemicalbrowser.com
Trade and customs footprint
Cipla recorded 1,525 shipments in customs data and sources pharmaceutical ingredients and finished medicines from India, Portugal, Greece, China, Spain, and 7 other countries globally. US customs bill-of-lading records list 790 inbound shipments across 18 foreign suppliers, with top origins including India · Oman · Spain · Netherlands.
Latest developments
2026-08-06 — Cipla to invest ₹200 crore; Rocket India ₹100 crore in Karnataka: Minister, ETManufacturing (indiatimes.com)
2026-06-16 — Cipla expands respiratory, specialty manufacturing across India, China, US | Company News - Business Standard (business-standard.com)
2026-03-20 — cipla invests up to 100m in us subsidiary for manufacturing and product launch | ICICI Direct (icicidirect.com)
2026-03-19 — Cipla approved investment up to USD 100 million in equity share capital of Cipla (EU) Limited | MarketScreener (marketscreener.com)
2026-03-02 — Cipla, Kemwell form biologics JV to tap fast-growing biosimilars market | Industry News - Business Standard (business-standard.com)
2025-12-03 — Cipla partners with Stempeutics, launches Stem Cell Therapy for Knee Osteoarthritis | Cipla (cipla.com)
Facilities
Cipla is headquartered in Mumbai, Maharashtra. Public sources also reference these locations:
Fall River, MA — prnewswire.com
Company details
Cipla is drug producer in India with a workforce exceeding 26,000 employees and maintains a joint venture with Kemwell focused on biosimilars development. Cipla was founded in 1935, has an estimated 10,000-50,000 employees, and is headquartered in Mumbai, Maharashtra. On the LightSource stability read it is rated "Established & active": 91 years in operation (founded 1935). 790 US import shipments on record. Holds ISO 14001, ISO 45001, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Cipla do?
Cipla Limited is a multinational pharmaceutical manufacturer headquartered in Mumbai, India, founded in 1935. The company employs 10,000–50,000 people and generates $1–5 billion in estimated annual revenue. It produces over 1,500 medicines across respiratory, cardiovascular, anti-retroviral, and oncology therapeutic areas, serving automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors across 74–86 countries. Recent expansion includes a planned $100 million investment in its US subsidiary for manufacturing and product launches.
Where is Cipla headquartered?
Cipla is headquartered in Mumbai, Maharashtra (Ganpatrao Kadam Marg, Mumbai, Maharashtra, 400013).
When was Cipla founded?
Cipla was founded in 1935.
How big is Cipla?
Cipla has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).
What certifications does Cipla hold?
Cipla lists ISO 14001 · ISO 45001 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Does Cipla import from overseas suppliers?
US customs bill-of-lading records show 790 inbound shipments for Cipla, with top origins including India · Oman · Spain · Netherlands.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Phone
'+1 222-482-6000
Certification
ISO 14001 · ISO 45001 · ISO 9001
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
